Plasma Free Fatty Acids in Risk Assessment of Sepsis in the Emergency Department: A Prospective Pilot Study
NCT01530854
Disease Attributes, Emergencies
Cleveland, Ohio, United States
View Trial DetailsNCT Number: NCT02738164
Investigators aim to evaluate the SEPSIS 3 criterion for "sepsis" and "septic shock" in a prospective manner.
Investigators will evaluate qSOFA performances and other SEPSIS 3 criterion in a population of emergency patients with infection
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
St Luc, Brussels, Belgium
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 30 days
Time frame: 30 days
Time frame: 30 days
Time frame: 30 days
Societe Française de Medecine d'urgence
Other
Validation of the SEPSIS-3 Criterion for Sepsis and Septic Shock in the Emergency Department
Acronym: SCREEN
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01530854
Disease Attributes, Emergencies
Cleveland, Ohio, United States
View Trial DetailsNCT04580888
Disease Attributes, Echocardiography
Albi, France
View Trial DetailsNCT07134868
Disease Attributes, Emergencies
Sakarya, Adapazarı, Turkey (Türkiye)
View Trial DetailsNCT07020598
Disease Attributes, Emergencies
View Trial Details